Effect of the combination of bumetanide plus chlorthalidone on hypertension and volume overload in patients with chronic kidney disease stage 4–5 KDIGO without renal replacement therapy: a double-blind…

Overview of attention for article published in BMC Nephrology, September 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (61st percentile)
Above-average Attention Score compared to outputs of the same age and source (59th percentile)

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 29,144 followers.

RT @NephroSeeker: 7/ advancing in CKD stages and comprehensive presentation: does CTD work in stage 5 CKD? #kidneywk https://t.co/M60yQZ…

RT @NephroSeeker: 7/ advancing in CKD stages and comprehensive presentation: does CTD work in stage 5 CKD? #kidneywk https://t.co/M60yQZ…

7/ advancing in CKD stages and comprehensive presentation: does CTD work in stage 5 CKD? #kidneywk https://t.co/M60yQZYWua https://t.co/JU6mkaoXHf

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.